POSA258 Leveraging RWE and Integrating Multi-Source Data to Build the Case for Funding and Access for Rare Disease Drugs von Stavropoulou, A, Teale, C, Paydas, L, Harrow, G, Roldan-Gomendio, A

Volltext

3D thermal finite element analysis of laser cladding processed Ti-6Al-4V part with microstructural correlations von Tran, H.-S., Tchuindjang, J.T., Paydas, H., Mertens, A., Jardin, R.T., Duchêne, L., Carrus, R., Lecomte-Beckers, J., Habraken, A.M.

Volltext

REAL‐LIFE EXPERIENCE WITH RITUXIMAB‐DOSE‐ADJUSTED EPOCH (R‐da‐EPOCH) IN PRIMARY MEDIASTINAL LARGE B‐CELL LYMPHOMA (PMLBCL): A MULTINATIONAL ANALYSIS OF 274 PATIENTS von Vassilakopoulos, T., Ferhanoglu, B., Horowitz, N., Mellios, Z., Kaynar, L., Zektser, M., Symeonidis, A., Piperidou, A., Giotas, A., Agathocleous, A., Kalpadakis, C., Akay, O., Atalar, S., Katodritou, E., Leonidopoulou, T., Papageorgiou, S., Tadmor, T., Gutwein, O., Karakatsanis, S., Ganzel, C., Karianakis, C., Isenberg, G., Gainaru, G., Vrakidou, E., Palassopoulou, M., Ozgur, M., Siakantaris, M., Paydas, S., Tsirigotis, P., Tsirogianni, M., Hatzimichael, E., Tuglular, T., Chatzidimitriou, C., Megalakaki, E., Kanellias, N., Zikos, P., Koumarianou, A., Gafter‐Gvili, A., Angelopoulou, M., Karmiris, T., Gurion, R.

Volltext

124P Talazoparib in locally advanced or metastatic breast cancer patients: Experience from an early access program in Turkey von Sendur, M.A.N., Cakar, B., Hızal, M., Eraslan, E., Aksoy, S., Paydas, S., Demir, N., Sen, F., Bulut, G., Oruc, K., Oyan Uluc, B., Ozdemir, N., Sakin, A., Erdem, D., Ozkan, M., Disel, U., Ekinci, F., Okten, I.N., Ozer, L., Gokmen, E.

Volltext

Brentuximab vedotin for relapsed or refractory Hodgkin lymphoma: experience in Turkey von Salihoglu, A., Elverdi, T., Karadogan, I., Paydas, S., Ozdemir, E., Erdem, G., Karadurmus, N., Akyol, G., Kaynar, L., Yegin, ZA, Sucak, G., Ozkocaman, V., Topcuoglu, P., Ozcan, M., Birtas, E., Goker, H., Baslar, Z., Ferhanoglu, B.

Volltext

GLASS: Global Lorlatinib for ALK(+) and ROS1(+) retrospective Study: real world data of 123 NSCLC patients von Peled, Nir, Gillis, Roni, Kilickap, Saadettin, Froesch, Patrizia, Orlov, Sergei, Filippova, Elena, Demirci, Umut, Christopoulos, Petros, Cicin, Irfan, Basal, Fatma Bugdayci, Yilmaz, Cengiz, Fedor, Moiseenko, Korkmaz, Taner, Paydas, Semra, Gautschi, Oliver, Zirtiloglu, Alisan, Eralp, Yesim, Cinkir, Havva Yesil, Sezer, Ahmet, Erman, Mustafa, Tural, Deniz, Turna, Hande, Mazieres, Julien, Dudnik, Elizabeth, Reguart, Noemi, Camidge, David Ross, Ng, Terry L., Şenler, Filiz Çay, Beypınar, İsmail, Yazılıtaş, Doğan, Demirkazık, Ahmet, Karaoğlu, Aziz, Okutur, Kerem, Coşkun, Hasan Şenol, Şendur, Mehmet Ali Nahit, Isikdogan, Abdurrahman, Cabuk, Devrim, Yumuk, Perran Fulden, Yıldız, Ibrahim, Kaplan, M. Ali, Özyılkan, Özgür, Öztop, İlhan, Olmez, Omer Fatih, Aydin, Kübra, Aydıner, Adnan, Meydan, Nezih, Grinberg, Roxana Denisa, Roisman, Laila C.

Volltext

RITUXIMAB‐DOSE‐ADJUSTED EPOCH (R‐DA‐EPOCH) IN PRIMARY MEDIASTINAL LARGE B‐CELL LYMPHOMA (PMLBCL): REAL‐LIFE EXPERIENCE ON 190 PATIENTS FROM 3 MEDITERRANEAN COUNTRIES von Vassilakopoulos, T., Ferhanoglu, B., Horowitz, N., Mellios, Z., Kaynar, L., Zektser, M., Symeonidis, A., Piperidou, A., Kalpadakis, C., Akay, O. M., Atalar, A. C., Katodritou, E., Leonidopoulou, T., Papageorgiou, S., Tadmor, T., Gutwein, O., Karakatsanis, S., Ganzel, C., Karianakis, G., Isenberg, G., Gainaru, G., Vrakidou, E., Palassopoulou, M., Ozgur, M., Siakantaris, M., Paydas, S., Tsirigotis, P., Tsirogianni, M., Hatzimichael, E., Tuglular, T., Chatzidimitriou, C., Megalakaki, E., Kanellias, N., Zikos, P., Koumarianou, A., Gafter‐Gvili, A., Angelopoulou, M., Karmiris, T., Gurion, R.

Volltext

P1178: THE APPLICABILITY OF PROGNOSTIC MODELS UNDER RITUXIMAB‐DOSE‐ADJUSTED EPOCH (R‐DA‐EPOCH) IN PRIMARY MEDIASTINAL LARGE B‐CELL LYMPHOMA (PMLBCL): A COMPARISON WITH R‐CHOP... von Vassilakopoulos, Theodoros, Ferhanoglu, B, Horowitz, Na, Apostolidis, J, Mellios, Z, Piperidou, Alexia, Kaynar, L, Zektser, M, Giotasmater, A, Hospital, Dei, Malta, Msida, Symeonidis, A, Kalpadakis, C, Agathocleous, A, Akay, Om, Sayyed, A, Atalar, Sc, Katodritou, E, Leonidopoulou, T, Papageorgiou, Sg, Tadmor, T., Gutwein, O, Karakatsanis, S, Ganzel, C, Karianakis, G., Isenberg, G. Y., Gainaru, G, Vrakidou, E., Palassopoulou, M, Ozgur, M, Siakantaris, Marina, Paydas, S, Tsirigotis, P, Tsirogianni, M, Hatzimichael, E, Tugular, Tf, Assimakopoulos, Jv, Ligdi, L, Liaskas, A, Aikaterini Lefaki, Maria, Labropoulou, P, Kopsaftopoulou, A, Verrou, E, Kanellias, M, Zikos, P, Koumarianou, A, Gafter‐Gvili, A, Bouzani, M, Angelopoulou, Mk, Karmiris, T, Gurion, R

Volltext

Nivolumab for relapsed or refractory Hodgkin lymphoma: real-life experience von Beköz, H., Karadurmuş, N., Paydaş, S., Türker, A., Toptaş, T., Fıratlı Tuğlular, T., Sönmez, M., Gülbaş, Z., Tekgündüz, E., Kaya, A.H., Özbalak, M., Taştemir, N., Kaynar, L., Yıldırım, R., Karadoğan, I., Arat, M., Pepedil Tanrıkulu, F., Özkocaman, V., Abalı, H., Turgut, M., Kurt Yüksel, M., Özcan, M., Doğu, M.H., Kabukçu Hacıoğlu, S., Barışta, I., Demirkaya, M., Köseoğlu, F.D., Toprak, S.K., Yılmaz, M., Demirkürek, H.C., Demirkol, O., Ferhanoğlu, B.

Volltext

P1229: RITUXIMAB‐DOSE‐ADJUSTED EPOCH (R‐DA‐EPOCH) IN PRIMARY MEDIASTINAL LARGE B‐CELL LYMPHOMA (PMLBCL): REAL‐LIFE EXPERIENCE ON 225 PATIENTS FROM 4 COUNTRIES von Vassilakopoulos, T., Ferhanoglu, B., Horowitz, N. A., Apostolidis, J., Mellios, Z., Kaynar, L., Zektser, M., Symeonidis, A., Piperidou, A., Kalpadaki, C., Akay, O. M., Atalar, S. C., Sayyed, A., Katodritou, E., Leonidopoulou, T., Papageorgiou, S., Tadmor, T., Gutwein, O., Karakatsanis, S., Ganzel, C., Karianakis, G., Isenberg, G., Gainaru, G., Vrakidou, E., Palassopoulou, M., Ozgur, M., Siakantaris, M., Paydas, S., Tsirigotis, P., Tsirogianni, M., Hatzimichael, E., Tuglular, T. F., Chatzidimitriou, C., Liaskas, A., Lefaki, M. A., Kanellias, N., Zikos, P., Koumarianou, A., Gafter‐Gvili, A., Angelopoulou, M., Karmiris, T., Gurion, R.

Volltext

P84.03 GLASS: Global Lorlatinib for ALK(+) and ROS1(+) Retrospective Study: Real World Data of 123 NSCLC Patients von Peled, N., Gillis, R., Kilickap, S., Froesch, P., Orlov, S., Filippova, E., Demirci, U., Christopoulos, P., Cicin, I., Bugdayci Basal, F., Yilmaz, C., Fedor, M., Korkmaz, T., Paydas, S., Gautschi, O., Zirtiloglu, A., Eralp, Y., Cinkir, H.Y., Sezer, A., Erman, M., Tural, D., Turna, H.Z., Mazieres, J., Dudnik, E., Reguart, N., Camidge, R., Ng, T.L., Senler, F. Cay, Beypınar, İ., Yazılıtaş, D., Demirkazik, A., Karaoğlu, A., Okutur, K., Şenol Coşkun, H., Nahit Şendur, M.A., Isikdogan, A., Cabuk, D., Yumuk, P.F., Yıldız, I., Kaplan, M.A., Özyılkan, Ö., Öztop, İ., Olmez, O.F., Aydin, K., Aydıner, A., Meydan, N., Grinberg, R., Roisman, L.

Volltext

Nivolumab for relapsed or refractory Hodgkin lymphoma: Experience in Turkey von Ferhanoglu, B., Bekoz, H., Karadurmus, N., Paydas, S., Gulbas, Z., Turker, A., Toptas, T., Firatli Tuglular, T., Tekgunduz, E., Kaya, A., Tastemir, N., Arat, M., Pepedil Tanrikulu, F., Ozkocaman, V., Abali, H., Turgut, M., Kaynar, L., Karadogan, I., Ozbalak, M., Dogu, M., Kabukcu Hacioglu, S., Yildirim, R., Barista, I., Kurt Yuksel, M., Sonmez, M.

Volltext

Nivolumab for relapsed or refractory H odgkin lymphoma: Experience in T urkey von Ferhanoglu, B., Bekoz, H., Karadurmus, N., Paydas, S., Gulbas, Z., Turker, A., Toptas, T., Firatli Tuglular, T., Tekgunduz, E., Kaya, A., Tastemir, N., Arat, M., Pepedil Tanrikulu, F., Ozkocaman, V., Abali, H., Turgut, M., Kaynar, L., Karadogan, I., Ozbalak, M., Dogu, M., Kabukcu Hacioglu, S., Yildirim, R., Barista, I., Kurt Yuksel, M., Sonmez, M.

Volltext

PS1245 NIVOLUMAB FOR RELAPSED OR REFRACTORY HODGKIN LYMPHOMA: LONG TERM RESULTS OF MULTI‐CENTER EXPERIENCE IN TURKEY von Ferhanoglu, B., Ozbalak, M., Bekoz, H., Karadurmus, N., Paydas, S., Turker, A., Toptas, T., Tuglular, T. Firatli, Sonmez, M., Gulbas, Z., Demir, N., Kaynar, L., Yildirim, R., Karadogan, I., Arat, M., Tanrikulu, F. Pepedil, Ozkocaman, V., Abali, H., Turgut, M., Yuksel, M. Kurt, Ozcan, M., Hacioglu, S. Kabukcu, Barista, I., Demirkaya, M., Atilla, F.D., Toprak, S.K., Yilmaz, M.

Volltext

Worse patient- physician relationship is associated with more fear of cancer recurrence (Deimos Study): A study of the palliative care working committee of the Turkish Oncology Gro... von Alkan, A., Yaşar, A., Güç, Z.G., Gürbüz, M., Başoğlu, T., Sezgin Göksu, S., Buğdaycı Başal, F., Türk, H.M., Özdemir, Ö, Yeşil Çınkır, H., Güven, D.C., Kuş, T., Türker, S., Koral, L., Karakaş, Y., Ak, N., Paydaş, S., Karcı, E., Tanrıverdi, Ö, Çay Şenler, F.

Volltext

1617PDWorse patient- physician relationship is associated with more fear of cancer recurrence (Deimos Study): A study of the palliative care working committee of the Turkish Oncolo... von Alkan, A, Yaşar, A, Güç, Z G, Gürbüz, M, Başoğlu, T, Sezgin Göksu, S, Buğdaycı Başal, F, Türk, H M, Özdemir, Ö, Yeşil Çınkır, H, Güven, D C, Kuş, T, Türker, S, Koral, L, Karakaş, Y, Ak, N, Paydaş, S, Karcı, E, Tanrıverdi, Ö, Çay Şenler, F

Volltext

1617PD - Worse patient- physician relationship is associated with more fear of cancer recurrence (Deimos Study): A study of the palliative care working committee of the Turkish Onc... von Alkan, A., Yaşar, A., Güç, Z.G., Gürbüz, M., Başoğlu, T., Sezgin Göksu, S., Buğdaycı Başal, F., Türk, H.M., Özdemir, Ö, Yeşil Çınkır, H., Güven, D.C., Kuş, T., Türker, S., Koral, L., Karakaş, Y., Ak, N., Paydaş, S., Karcı, E., Tanrıverdi, Ö, Çay Şenler, F.

Volltext

Oxidative-Antioxidative System in Peripartum Acute Renal Failure and Preeclampsia-Eclampsia von Balal, Mustafa, Canacankatan, Necmiye, Paydas, Saime, Seyrek, Neslihan, Karayaylali, Ibrahim, Kayr n, Levent

Volltext

Serum levels of tumor necrosis factor in squamous cell carcinoma of the head and neck von Soylu, Levent, Özcan, Cengiz, Çetik, Fikret, Paydaş, Semra, Kiroǧlu, Mete, Aydoǧan, Barlas, Sargin, Özoḡul, Özşahinoḡlu, Can, Seyrek, Ertuǧru

Volltext

Small cell carcinoma of the larynx von Soylu, Levent, Özcan, Cengiz, Çetik, Fikret, Paydaş, Semra, Kiroǧlu, Mete, Aydoǧan, Barlas, Tuncer, Ilhan, Javadzadeh, Ahmet, Şahin, Berksoy, Özsahinoǧlu, Can

Volltext